Literature DB >> 2972846

A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy.

J E Kaplan1, T J Spira, D B Fishbein, L H Bozeman, P F Pinsky, L B Schonberger.   

Abstract

Seventy-five homosexual men with generalized lymphadenopathy for at least three months (lymphadenopathy syndrome [LAS]), subsequently shown to be seropositive for antibody against human immunodeficiency virus, were enrolled in a prospective study in Atlanta in 1982 and 1983. As of Nov 30, 1987, twenty-two (29%) of the 75 were known to have developed acquired immunodeficiency syndrome (AIDS) three to 60 months after enrollment and five to 69 months after onset of LAS. The six-year cumulative incidence of AIDS, by Kaplan-Meier survival analysis, was 38%. The cumulative incidence in years 4, 5, and 6 (30%) was significantly higher than in years 1, 2, and 3 (11%), suggesting that the risk for AIDS increases after the third year of LAS and that many more study participants will eventually develop AIDS. A precipitous decline in the T-helper cell count frequently heralds the diagnosis of AIDS; this decrease appears to occur at different times after the onset of LAS in different persons. The four-year cumulative incidence of AIDS following observations of T-helper cell counts less than 200/mm3, 200 to 299/mm3, 300 to 399/mm3, and 400/mm3 or greater was 84%, 41%, 25%, and 18%, respectively; these data are important for determining prognosis in the individual patient as well as for determining the suitability of candidates and baseline data for drug trials.

Entities:  

Mesh:

Year:  1988        PMID: 2972846

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  Clinical and immunological assessment of HIV infection.

Authors:  A G Bird
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

2.  When should asymptomatic patients with HIV infection be treated with zidovudine?

Authors:  B G Gazzard
Journal:  BMJ       Date:  1992-02-22

3.  Prevalence of HIV infection in 646 heroin addicts and outcome of HIV-related conditions in the 266 followed up.

Authors:  C Mandelli; D Conte; R Barbera; T Masullo; S Pistoso; G P Aimo; L Cesarini; M Fraguelli; G P Lorini; P A Bianchi
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

4.  The natural history of human immunodeficiency virus infection: a five year study in a London cohort of homosexual men.

Authors:  G E Kelly; B S Stanley; I V Weller
Journal:  Genitourin Med       Date:  1990-08

5.  Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.

Authors:  L M Aledort; M W Hilgartner; M C Pike; G F Gjerset; M A Koerper; E Y Lian; J M Lusher; J W Mosley
Journal:  BMJ       Date:  1992-01-25

6.  Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: prognostic implications.

Authors:  T J Spira; J E Kaplan; R C Holman; L H Bozeman; J K Nicholson; D B Fishbein
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 7.  Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention.

Authors:  H Atlan; M J Gersten; P L Salk; J Salk
Journal:  Res Immunol       Date:  1994 Mar-Apr

8.  The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection.

Authors:  Quentin Le Hingrat; Irini Sereti; Alan L Landay; Ivona Pandrea; Cristian Apetrei
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.